Lucky Mark Burdon purchased $4K of VISM (indirect holdings)

Lucky Mark Burdon (CFO and Interim Principal) purchased 125,105 indirectly-held shares of VISIUM TECHNOLOGIES, INC. (VISM) at an average of $0.03 ($0.01–$0.45) across 10 trades over 2022-11-28 to 2023-09-22.

Original reporting
SEC EDGAR · Lucky Mark Burdon
Published Oct 29, 2026, 7:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 7:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VISM
Bullish
medium confidence
Mentioned
$VISM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VISMBullishLow
01

Why it matters

The transaction is a primary disclosure but of modest scale, offering limited trading insight.

02

Market read

Small insider purchase with limited price impact; primarily of interest to existing shareholders.

03

What to watch

Potential upcoming clinical data or financing events could amplify the effect of insider activity.

Relevance 3/10Novelty 3/10Timing: filed today

Background

Visium Technologies filed a Form 4 showing a recent insider purchase by its CFO.

Company-level read

Ticker impact

$VISMBullishMedium confidence
Context

CFO Lucky Mark Burdon purchased 125,105 shares of Visium Technologies for $4,121, indicating insider confidence.

Expected impact

modest upward pressure as the market prices in the insider buy

Evidence & confidence

A CFO buying a small stake signals confidence, but the total amount is modest relative to market cap.

Market effects

Limited impact on the broader biotech sector.

No significant regional effect.

Minimal global relevance.

Counterpoint

The purchase size is too small to move the stock; investors may ignore it.

Key entities

  • Lucky Mark Burdon

    CFO and interim principal of Visium Technologies.

  • Visium Technologies, Inc.

    Biotech firm listed on NASDAQ under VISM.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VISMMed

Dr. Bo Niclas Adler Discloses Investment at Visium Technologies with 48.8% Stake

Dr. Bo Niclas Adler, owner of PT Smart Green Technologies, disclosed a 48.8% stake in Visium Technologies (VISM) via a Schedule 13D filing. The stake includes 620 million common shares and convertible preferred shares. Adler and the company discussed potential acquisitions and board changes, but no agreements were reached. PT Smart Green Technologies focuses on AI infrastructure in Indonesia.

$LYELMedAI 8/10

ARCH Venture Fund XIII, L.P. (CRANDELL KEITH, GILLIS STEVEN) purchased $25.0M of LYEL (indirect holdings)

ARCH Venture Fund XIII, L.P. purchased 2,321,262 indirectly-held shares of Lyell Immunopharma, Inc. (LYEL) at $10.77 ($25.00M total) on 2026-11-04. Filed jointly with ARCH Venture Partners XIII, L.P. (10% owner), ARCH Venture Partners XIII, LLC (10% owner), CRANDELL KEITH (10% owner), GILLIS STEVEN (10% owner), NELSEN ROBERT (10% owner), Burow Kristina (10% owner), BERNS PAUL L (10% owner) and BYBEE CLINTON (10% owner).